Free tool
Healthcare stocks
We cover 1,633 companies in the Healthcare sector. The median market value in the group is $270.38M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is +0.56%. 48% of the 967 with a 200-day average trade above it. Price change over the past year runs from −47.8% to +120.4% across the middle 80 percent of the group, with a median of +0.5%. Among those 1,000, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,633 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | $18.92 | +19.07% | −11.22% | +4.76% |
| GHRS | GH Research PLC | $28.92 | +4.22% | +118.43% | +119.42% |
| PGNY | Progyny, Inc. | $25.45 | −19.44% | −1.13% | +9.98% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | 4.82 BRL | +15.04% | −17.18% | −2.43% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +0.71% | +15.22% | +8.44% |
| SNDA | Sonida Senior Living, Inc. | $40.97 | −4.32% | +28.31% | +57.21% |
| FLRY3.SA | Fleury S.A. | 18.64 BRL | +12.76% | +25.69% | +39.13% |
| ZYME | Zymeworks Inc. | $27.47 | +19.43% | +3.19% | +88.54% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $33.90 | −8.30% | +24.72% | −9.02% |
| LKFT | Lakefront Biotherapeutics NV | $29.70 | +5.58% | −9.92% | −5.53% |
| SEPN | Septerna, Inc. | $41.30 | +23.32% | +47.61% | +245.32% |
| IMCR | Immunocore Holdings plc | $37.40 | +10.75% | +10.72% | +14.76% |
| RXRX | Recursion Pharmaceuticals, Inc. | $3.56 | +18.27% | −15.24% | −26.29% |
| NTLA | Intellia Therapeutics, Inc. | $13.51 | +26.62% | +46.69% | +18.72% |
| DMRA | Damora Therapeutics, Inc. | $30.62 | +4.01% | +40.33% | +800.59% |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.41% | −12.36% | −44.50% |
| ALVO-SDB.ST | Alvotech SDB | 49.65 SEK | +55.89% | +8.57% | −34.75% |
| ASTH | Astrana Health, Inc. | $37.61 | −1.52% | +49.13% | +25.66% |
| PSNL | Personalis, Inc. | $17.25 | +43.99% | +119.75% | +267.02% |
| SGRY | Surgery Partners, Inc. | $14.05 | −7.38% | −7.93% | −39.02% |
| BLFS | BioLife Solutions, Inc. | $37.22 | +24.94% | +55.80% | +45.11% |
| VIR | Vir Biotechnology, Inc. | $10.71 | +21.70% | +80.30% | +144.52% |
| INBX | Inhibrx Biosciences, Inc. | $122.72 | +48.84% | +63.54% | +390.10% |
| LMAT | LeMaitre Vascular, Inc. | $78.97 | −20.18% | −1.03% | −18.51% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | 82.60 EUR | +8.68% | +53.24% | +52.14% |
| ETON | Eton Pharmaceuticals, Inc. | $63.05 | +49.02% | +287.76% | +268.93% |
| ALVO | Alvotech | $5.05 | +63.96% | +1.00% | −39.30% |
| 4540.T | Tsumura & Co. | 3,799.00 JPY | −3.31% | −5.99% | +9.38% |
| INSP | Inspire Medical Systems, Inc. | $61.07 | +19.91% | −33.81% | −34.28% |
| SNDX | Syndax Pharmaceuticals, Inc. | $19.92 | −2.92% | −6.48% | +27.20% |
| ATT.ST | Attendo AB (publ) | 117.70 SEK | +6.42% | +48.97% | +75.11% |
| ANIP | ANI Pharmaceuticals, Inc. | $75.65 | −3.47% | −3.54% | −16.24% |
| FTRE | Fortrea Holdings Inc. | $18.27 | −4.84% | +8.69% | +106.21% |
| ANAB | AnaptysBio, Inc. | $58.37 | +8.88% | +94.78% | +335.60% |
| AVLN | Avalyn Pharma Inc. | $38.20 | +38.31% | +29.54% | +29.54% |
| MAZE | Maze Therapeutics, Inc. | $30.42 | +6.03% | −23.51% | +128.55% |
| 7716.T | Nakanishi Inc. | 3,215.00 JPY | +4.38% | +61.15% | +55.31% |
| CLARI.PA | Clariane SE | 4.06 EUR | +2.37% | +3.31% | −7.85% |
| SIA.TO | Sienna Senior Living Inc. | 21.47 CAD | −6.54% | +6.94% | +25.31% |
| ABSI | Absci Corporation | $9.63 | +27.38% | +166.76% | +279.13% |
| 4DX.AX | 4DMedical Limited | 3.84 AUD | +18.15% | −15.42% | +652.94% |
| FBRX | Forte Biosciences, Inc. | $76.97 | +0.61% | +226.01% | +580.25% |
| BCAX | Bicara Therapeutics Inc. | $24.58 | −11.61% | +50.06% | +117.14% |
| 8129.T | Toho Holdings Co., Ltd. | 3,973.00 JPY | −5.85% | −13.10% | −22.82% |
| 8086.T | Nipro Corporation | 1,580.00 JPY | −2.89% | +7.33% | +6.42% |
| AGL | agilon health, inc. | $96.11 | −2.36% | +470.39% | +178.58% |
| TRAX | First Tracks Biotherapeutics, Inc. | $45.11 | +7.33% | +137.42% | +137.42% |
| ARDT | Ardent Health, Inc. | $11.30 | +3.20% | +30.79% | −10.95% |
| XERS | Xeris Biopharma Holdings, Inc. | $8.74 | +6.46% | +18.91% | +12.48% |
| TYRA | Tyra Biosciences, Inc. | $26.69 | −14.07% | −0.37% | +122.42% |
| OMCL | Omnicell, Inc. | $33.22 | −19.93% | −26.41% | +0.39% |
| KMTS | Kestra Medical Technologies, Ltd. | $26.92 | +17.97% | +10.37% | +51.92% |
| HCSG | Healthcare Services Group, Inc. | $22.94 | −0.04% | +32.22% | +48.10% |
| LBRX | LB Pharmaceuticals Inc | $48.80 | +40.31% | +138.75% | +182.08% |
| AAPG | Ascentage Pharma Group Internat | $16.79 | −11.12% | −36.33% | −61.38% |
| NVAX | Novavax, Inc. | $9.44 | +26.03% | +32.40% | +25.53% |
| BONEX.ST | Bonesupport Holding AB (publ) | 219.20 SEK | +2.05% | +23.15% | −25.64% |
| AVBP | ArriVent BioPharma, Inc. | $31.35 | +3.95% | +50.72% | +62.02% |
| DIA.WA | Diagnostyka S.A. | 166.50 PLN | +0.54% | −3.70% | −17.53% |
| CNMD | CONMED Corporation | $51.13 | +17.51% | +26.18% | −5.45% |
| INVA | Innoviva, Inc. | $21.17 | −0.61% | +6.54% | +7.14% |
| 4516.T | Nippon Shinyaku Co., Ltd. | 3,609.00 JPY | +0.81% | −34.02% | +18.84% |
| 6849.T | Nihon Kohden Corporation | 1,520.50 JPY | −5.73% | −9.30% | −5.62% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | 58.02 BRL | +4.58% | +25.99% | +301.52% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $22.22 | +29.41% | +3.11% | +83.48% |
| SDGR | Schrödinger, Inc. | $19.99 | +30.82% | +11.18% | +2.30% |
| REPL | Replimune Group, Inc. | $15.80 | +83.08% | +77.53% | +187.80% |
| AKTS | Aktis Oncology, Inc. | $26.69 | +10.24% | +19.15% | +19.15% |
| INNV | InnovAge Holding Corp. | $10.92 | −4.88% | +110.40% | +197.55% |
| PYC.AX | PYC Therapeutics Limited | 2.12 AUD | +30.46% | +28.10% | +63.71% |
| CGEM | Cullinan Therapeutics, Inc. | $22.95 | +31.67% | +126.78% | +200.39% |
| AMBEA.ST | Ambea AB (publ) | 170.50 SEK | +19.48% | +25.09% | +32.95% |
| NOLA-B.ST | Nolato AB (publ) | 51.70 SEK | +7.04% | −10.45% | −8.30% |
| ENOV | Enovis Corporation | $25.58 | −9.45% | −3.51% | −17.46% |
| OMDA | Omada Health, Inc. | $23.94 | +16.33% | +60.67% | +14.00% |
| PAHC | Phibro Animal Health Corporation | $35.93 | +1.96% | −3.45% | +13.43% |
| RDC.DE | Redcare Pharmacy NV | 61.30 EUR | −9.65% | −7.19% | −31.39% |
| AZTA | Azenta, Inc. | $33.21 | +20.68% | −0.54% | +7.96% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +107.85% |
| ATEC | Alphatec Holdings, Inc. | $9.33 | +7.61% | −55.06% | −41.10% |
| MGTX | MeiraGTx Holdings plc | $14.92 | +21.30% | +91.04% | +96.83% |
| ANRO | Alto Neuroscience, Inc. | $36.31 | +30.28% | +118.87% | +821.57% |
| GDS.PA | Ramsay Générale de Santé SA | 11.10 EUR | +3.26% | +18.84% | +11.00% |
| 4483.T | JMDC Inc. | 3,430.00 JPY | +6.85% | −11.68% | −18.41% |
| 3148.T | Create SD Holdings Co., Ltd. | 3,450.00 JPY | +0.29% | +4.76% | +3.09% |
| OMER | Omeros Corporation | $19.28 | +70.02% | +17.70% | +343.22% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.83 | +15.06% | +69.28% | +43.76% |
| JBIO | Jade Biosciences, Inc. | $21.84 | +9.47% | +54.24% | +176.46% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | 6.50 EUR | −2.99% | −48.41% | −48.41% |
| 9627.T | Ain Holdings Inc. | 6,259.00 JPY | +4.09% | −3.94% | +4.41% |
| 3360.T | Ship Healthcare Holdings, Inc. | 2,383.50 JPY | −5.02% | −7.28% | +9.23% |
| P1RG34.SA | Perrigo Company plc | 50.71 BRL | −1.59% | −31.71% | −59.77% |
| VITR.ST | Vitrolife AB (publ) | 91.30 SEK | +5.55% | −30.65% | −31.27% |
| DRTS | Alpha Tau Medical Ltd. | $14.70 | +20.39% | +204.35% | +357.94% |
| CHEMM.CO | ChemoMetec A/S | 487.00 DKK | +17.86% | −27.80% | −4.56% |
| UPR.L | Uniphar plc | 360.00 GBP | −6.01% | +20.41% | +4.35% |
| MNKD | MannKind Corporation | $4.16 | +5.32% | −25.71% | +6.67% |
| PNTG | The Pennant Group, Inc. | $38.25 | −7.47% | +37.44% | +55.24% |
| MLTX | MoonLake Immunotherapeutics | $15.56 | −21.73% | +30.21% | −71.52% |
| REG.AX | Regis Healthcare Limited | 6.15 AUD | −1.60% | −10.32% | −19.77% |
| AMN | AMN Healthcare Services, Inc. | $33.91 | +1.38% | +124.27% | +63.90% |
| IART | Integra LifeSciences Holdings Corporation | $16.79 | −14.03% | +39.80% | +17.66% |
| VOR | Vor Biopharma Inc. | $24.01 | +23.51% | +106.27% | −41.72% |
| SPI.L | Spire Healthcare Group plc | 234.50 GBP | +0.43% | +38.77% | +5.16% |
| CRON | Cronos Group Inc. | $3.51 | +22.73% | +30.00% | +35.52% |
| CRON.TO | Cronos Group Inc. | 4.85 CAD | +19.46% | +31.44% | +34.72% |
| SPTX | Seaport Therapeutics, Inc. | $24.83 | +20.89% | +25.15% | +25.15% |
| AORT | Artivion, Inc. | $26.38 | +1.07% | −40.67% | −39.45% |
| NUTX | Nutex Health Inc. | $188.10 | +26.50% | +26.93% | +110.14% |
| IMTX | Immatics N.V. | $9.24 | +7.07% | −11.58% | +76.67% |
| ODTX | Odyssey Therapeutics, Inc. | $26.23 | +37.83% | +59.74% | +59.74% |
| 4544.T | H.U. Group Holdings, Inc. | 3,678.00 JPY | +5.93% | +9.61% | +11.45% |
| RYM.AX | RYM FPO NZX [RYM] | 1.73 AUD | −8.73% | −32.88% | −28.42% |
| BIOG-B.ST | BioGaia AB (publ) | 116.30 SEK | +0.87% | +14.26% | +14.81% |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.56 | −35.46% | −4.90% | +217.21% |
| CERT | Certara, Inc. | $8.14 | +5.03% | −6.86% | −24.70% |
| PRCT | PROCEPT BioRobotics Corporation | $21.60 | +22.10% | −29.78% | −45.05% |
| 2175.T | SMS Co., Ltd. | 2,404.00 JPY | +2.21% | +81.25% | +56.85% |
| SANA | Sana Biotechnology, Inc. | $4.10 | +25.00% | −2.15% | +22.39% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.56 | +12.69% | +98.91% | +167.16% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | 3,950.00 JPY | −4.13% | +10.32% | +34.73% |
| CVSG.L | CVS Group plc | 1,292.00 GBP | +2.95% | +1.41% | +0.47% |
| 6523.T | PHC Holdings Corporation | 1,541.00 JPY | +39.84% | +39.19% | +59.08% |
| 4887.T | Sawai Group Holdings Co., Ltd. | 1,632.00 JPY | −2.57% | −30.18% | −12.23% |
| GDRX | GoodRx Holdings, Inc. | $3.48 | +13.93% | +26.36% | −18.24% |
| AVNS | Avanos Medical Inc | $24.99 | +0.04% | +123.52% | +115.43% |
| STAA | STAAR Surgical Company | $23.18 | +1.00% | −1.78% | −15.68% |
| USPH | U.S. Physical Therapy, Inc. | $77.32 | +0.89% | −0.67% | −7.75% |
| TTALO.HE | Terveystalo Oyj | 7.68 EUR | +5.06% | −17.28% | −24.58% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | 14.70 EUR | +14.84% | +15.81% | +27.68% |
| SVRA | Savara Inc. | $5.60 | +3.13% | −0.71% | +78.34% |
| LMRI | Lumexa Imaging Holdings, Inc. | $12.07 | +9.23% | −31.23% | −34.83% |
| 2160.T | GNI Group Ltd. | 2,765.00 JPY | +12.58% | +20.74% | +4.54% |
| JANX | Janux Therapeutics, Inc. | $18.68 | +19.97% | +36.85% | −18.82% |
| T2DH34.SA | Teladoc Health, Inc. | 32.09 BRL | −29.80% | −15.77% | −23.05% |
| IVA.PA | Inventiva S.A. | 3.96 EUR | +0.64% | −2.22% | −14.58% |
| TDOC | Teladoc Health, Inc. | $6.19 | −30.53% | −12.20% | −19.30% |
| SNZ.AX | Summerset Group Holdings Limited | 6.45 AUD | −7.99% | −38.01% | −32.53% |
| PHIL.MI | Philogen S.p.A. | 23.35 EUR | −2.71% | +3.88% | +2.12% |
| IRMD | IRADIMED CORPORATION | $87.87 | −7.58% | −7.60% | +24.31% |
| SPH.WA | Sopharma AD | 8.40 PLN | +17.32% | −34.12% | −33.66% |
| OPK | OPKO Health, Inc. | $1.49 | +20.16% | +17.32% | +7.19% |
| IVA | Inventiva S.A. | $4.69 | +1.96% | −1.47% | +0.54% |
| 7476.T | AS ONE Corporation | 2,477.00 JPY | −2.09% | +4.79% | +2.10% |
| KURA | Kura Oncology, Inc. | $13.59 | +33.89% | +31.49% | +77.65% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | 89.55 BRL | +3.11% | +36.80% | +36.80% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | 4,125.00 JPY | −2.71% | −8.70% | −0.90% |
| 006280.KS | GC Biopharma Corp. | 129,300.00 KRW | +7.21% | −18.07% | −1.88% |
| AVTX | Avalo Therapeutics, Inc. | $19.74 | +1.23% | +15.98% | +110.00% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $2.34 | +4.93% | +105.26% | +107.08% |
| CADL | Candel Therapeutics, Inc. | $13.60 | +36.55% | +150.00% | +138.18% |
| WVE | Wave Life Sciences, Inc. | $5.25 | −11.32% | −67.08% | −47.18% |
| QDEL | QuidelOrtho Corporation | $15.05 | −10.58% | −47.71% | −45.57% |
| GUBRA.CO | Gubra A/S | 378.60 DKK | +1.01% | −29.10% | −2.92% |
| GXI.DE | Gerresheimer AG | 28.02 EUR | +5.58% | +0.79% | −33.73% |
| MEDCL.PA | MedinCell S.A. | 24.30 EUR | −3.72% | −1.70% | +40.14% |
| ABUS | Arbutus Biopharma Corporation | $5.20 | +17.91% | +9.01% | +48.57% |
| CLYM | Climb Bio Inc | $17.84 | +39.48% | +375.73% | +619.35% |
| CSTL | Castle Biosciences, Inc. | $35.00 | +43.21% | −9.19% | +70.15% |
| PCRX | Pacira BioSciences, Inc. | $25.53 | −3.55% | +4.37% | +0.67% |
| 7730.T | Mani, Inc. | 1,617.00 JPY | +6.80% | +11.06% | +32.50% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | 123,300.00 KRW | −2.07% | −25.72% | −10.28% |
| GERN | Geron Corporation | $1.55 | +4.73% | +17.42% | +9.15% |
| SLDB | Solid Biosciences Inc. | $9.89 | +25.35% | +81.47% | +76.61% |
| DSGN | Design Therapeutics, Inc. | $15.68 | +31.99% | +72.31% | +201.54% |
| ANNX | Annexon, Inc. | $5.15 | +0.39% | +9.81% | +139.53% |
| ARDX | Ardelyx, Inc. | $3.78 | −25.30% | −38.54% | −37.62% |
| IMMX | Immix Biopharma, Inc. | $14.47 | +66.51% | +166.48% | +589.05% |
| EUZ.DE | Eckert & Ziegler SE | 13.65 EUR | −0.29% | −9.06% | −23.06% |
| BVS | Bioventus Inc. | $14.08 | +13.09% | +95.28% | +89.25% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | 4,030.00 JPY | +3.07% | +2.67% | +10.48% |
| VETO.PA | Vetoquinol SA | 70.50 EUR | −3.16% | −16.47% | −6.50% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.91 | −9.16% | −56.84% | +95.17% |
| HELP | Cybin D/B/A Helus Pharma | $13.99 | +81.62% | +68.90% | +92.90% |
| DBVT | DBV Technologies S.A. | $14.97 | +7.70% | −21.42% | +52.91% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $21.98 | +14.60% | −16.93% | −26.32% |
| NEU.WA | NEUCA S.A. | 774.00 PLN | +2.52% | −7.31% | +17.99% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 280.00 SEK | +11.46% | +54.61% | +60.46% |
| ACRS | Aclaris Therapeutics, Inc. | $6.54 | +21.69% | +126.91% | +263.06% |
| DBV.PA | DBV Technologies S.A. | 2.44 EUR | +2.78% | −25.33% | +54.11% |
| 3046.T | JINS HOLDINGS Inc. | 6,310.00 JPY | −6.38% | +15.77% | −21.01% |
| CBLL | CeriBell, Inc. | $23.95 | +32.10% | +12.44% | +109.35% |
| PHN.MI | Pharmanutra S.p.A. | 82.20 EUR | −1.08% | +54.86% | +71.93% |
| B2RK34.SA | Bruker Corporation | 30.63 BRL | −0.49% | +63.27% | +63.27% |
| 4587.T | PeptiDream Inc. | 1,135.00 JPY | +22.00% | −29.98% | −28.26% |
| SGP | SpyGlass Pharma, Inc. | $26.60 | +27.76% | +0.76% | +0.76% |
| SYNSAM.ST | Synsam AB (publ) | 60.00 SEK | +6.19% | −7.21% | +9.18% |
| 7780.T | Menicon Co., Ltd. | 1,905.00 JPY | +7.99% | +22.88% | +57.22% |
| ANL | Adlai Nortye Ltd. | $13.74 | +13.93% | +895.65% | +737.80% |
| TBPH | Theravance Biopharma, Inc. | $17.03 | +1.01% | −6.17% | +23.45% |
| MCAP.ST | MedCap AB (publ) | 566.00 SEK | +3.10% | +6.19% | −8.86% |
| TALK | Talkspace, Inc. | $5.25 | +0.57% | +49.57% | +97.74% |
| BBNX | Beta Bionics, Inc. | $19.34 | +20.95% | −33.88% | +10.83% |
| SIBN | SI-BONE, Inc. | $19.54 | +14.60% | −1.26% | +21.74% |
| AVR | Anteris Technologies Global Corp. | $8.89 | +8.81% | +80.69% | +140.27% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.75 | +25.03% | +11.76% | +14.75% |
| INMD | InMode Ltd. | $15.03 | −2.28% | +1.55% | +3.16% |
| AVR.AX | Anteris Technologies Global Corp. | 12.07 AUD | +4.96% | +62.01% | +102.52% |
| 4694.T | BML, Inc. | 3,670.00 JPY | +1.66% | −2.27% | +7.64% |
| DYVOX.ST | Dynavox Group AB (publ) | 74.90 SEK | −0.07% | −23.54% | −39.04% |
| SFL.MI | Safilo Group S.p.A. | 1.88 EUR | +14.46% | −3.79% | +24.24% |
| COLL | Collegium Pharmaceutical, Inc. | $27.47 | −22.66% | −39.67% | −29.15% |
| OXB.L | Oxford Biomedica plc | 509.00 GBP | −8.45% | −22.29% | −8.62% |
| FDMT | 4D Molecular Therapeutics, Inc. | $15.72 | +51.45% | +114.75% | +133.23% |
| SLN | Silence Therapeutics plc | $13.67 | +13.26% | +122.28% | +170.16% |
| AHG | Akso Health Group | $0.98 | −32.59% | −38.49% | −44.40% |
| HSTM | HealthStream, Inc. | $28.87 | +3.59% | +27.07% | +4.49% |
| GNFT.PA | Genfit S.A. | 13.90 EUR | +5.30% | +164.76% | +293.99% |
| AMS.L | Advanced Medical Solutions Group plc | 282.00 GBP | +0.71% | +29.37% | +37.58% |
| PHAR | Pharming Group N.V. | $11.46 | −11.93% | −33.14% | −19.75% |
| APOTEA.ST | Apotea AB | 73.50 SEK | −0.41% | −18.06% | −29.63% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $3.18 | 0.00% | −14.29% | +47.91% |
| ARJO-B.ST | Arjo AB (publ) | 28.14 SEK | +4.30% | −7.67% | −17.06% |
| NGNE | Neurogene Inc. | $40.84 | +17.97% | +102.58% | +104.40% |
| ACHV | Achieve Life Sciences, Inc. | $8.17 | +32.20% | +64.39% | +146.83% |
| AURA | Aura Biosciences, Inc. | $7.82 | +9.22% | +47.55% | +19.94% |
| WELL.TO | WELL Health Technologies Corp. | 4.34 CAD | +8.77% | +7.16% | −10.70% |
| EIQ.AX | Echo IQ Limited | 1.55 AUD | +21.65% | +505.88% | +653.66% |
| STTK | Shattuck Labs, Inc. | $8.06 | +14.49% | +117.25% | +710.87% |
| SNT.WA | Synektik Spólka Akcyjna | 338.00 PLN | −6.78% | +21.68% | +53.56% |
| DRUG | Bright Minds Biosciences Inc. | $79.49 | +10.54% | −4.76% | +90.62% |
| VREX | Varex Imaging Corporation | $18.50 | +68.49% | +58.80% | +62.28% |
| NVCT | Nuvectis Pharma, Inc. | $25.89 | +32.50% | +204.23% | +298.92% |
| UU8.F | Neurogene Inc. | 32.20 EUR | +7.33% | +25.29% | +157.60% |
| 001067.KS | JW Pharmaceutical Corporation | 45,900.00 KRW | +5.88% | −21.56% | −21.42% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $9.37 | +7.09% | −23.76% | −3.50% |
| ALLO | Allogene Therapeutics, Inc. | $2.17 | +24.00% | +60.74% | +87.07% |
| MNPR | Monopar Therapeutics Inc. | $110.82 | +0.44% | +67.88% | +264.30% |
| AHCO | AdaptHealth Corp. | $5.48 | −50.00% | −43.33% | −40.63% |
| TECX | Tectonic Therapeutic, Inc. | $37.71 | +23.20% | +80.34% | +53.48% |
| SOPH | SOPHiA GENETICS SA | $8.65 | +53.10% | +85.22% | +150.72% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | 3,340.00 JPY | +4.87% | −4.62% | +8.68% |
| CTMX | CytomX Therapeutics, Inc. | $3.37 | +3.69% | −20.71% | +68.50% |
| D2OC34.SA | Doximity, Inc. | 21.20 BRL | +18.17% | −48.15% | −64.74% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $4.39 | +12.28% | +2.81% | +245.67% |
| DHT-UN.TO | DRI Healthcare Trust | 17.79 CAD | +1.95% | +11.64% | +28.36% |
| OCS | Oculis Holding AG | $12.96 | +17.60% | −35.20% | −27.15% |
| ASMB | Assembly Biosciences, Inc. | $35.33 | +36.36% | +4.68% | +32.72% |
| 4588.T | Oncolys BioPharma Inc. | 4,130.00 JPY | +65.80% | +176.44% | +526.71% |
| ZVRA | Zevra Therapeutics, Inc. | $12.04 | +24.00% | +44.36% | +28.63% |
| PHAT | Phathom Pharmaceuticals, Inc. | $8.66 | −27.53% | −44.88% | −25.15% |
| PHR | Phreesia, Inc. | $11.52 | +8.37% | −29.33% | −62.09% |
| SSII | SS Innovations International, Inc. | $3.55 | −10.35% | −37.17% | −49.14% |
| XOMA | XOMA Royalty Corp | $40.17 | 0.00% | +43.52% | +18.95% |
| 9267.T | Genky DrugStores Co., Ltd. | 3,690.00 JPY | −8.09% | −25.30% | −19.42% |
| C2RS34.SA | CRISPR Therapeutics AG | 36.81 BRL | +21.65% | +2.36% | −0.08% |
| BHVN34.SA | BIOHAVEN LTDDRN | 23.68 BRL | +3.14% | −1.09% | −18.03% |
| 7575.T | Japan Lifeline Co., Ltd. | 1,578.00 JPY | +10.81% | +1.42% | +12.56% |
| GUD.TO | Knight Therapeutics Inc. | 9.75 CAD | −0.71% | +64.97% | +49.08% |
| PROK | ProKidney Corp. | $1.73 | +12.34% | −22.42% | −26.38% |
| AGMB | AgomAb Therapeutics NV | $14.02 | +12.07% | −4.30% | −4.30% |
| DHT-U.TO | DRI Healthcare Trust | $12.56 | +0.88% | +6.68% | +27.68% |
| GMRS | GMR Solutions Inc. | $12.70 | −0.16% | −9.16% | −9.16% |
| GYRE | Gyre Therapeutics, Inc. | $6.68 | +8.97% | −1.91% | −18.54% |
| EIKN | Eikon Therapeutics, Inc. | $12.55 | +27.02% | −16.33% | −16.33% |
| OABI | OmniAb, Inc. | $4.66 | +129.56% | +147.87% | +185.89% |
| EVT.DE | Evotec SE | 3.27 EUR | −6.56% | −40.71% | −44.85% |
| PRME | Prime Medicine, Inc. | $3.71 | +23.26% | +5.10% | +5.40% |
| EVO | Evotec SE | $1.89 | −1.56% | −40.57% | −47.06% |
| TLRY | Tilray Brands, Inc. | $4.72 | +17.12% | −51.44% | −66.04% |
| TLRY.TO | Tilray Brands, Inc. | 6.58 CAD | +15.03% | −50.71% | +237.44% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.48 AUD | +16.98% | −33.15% | −27.91% |
| CRMD | CorMedix Inc. | $8.56 | +12.63% | −29.61% | −37.65% |
| LBIRD.PA | Lumibird SA | 25.80 EUR | −4.27% | +23.06% | +58.39% |
| AYJ.DE | Valneva SE | 2.86 EUR | +29.01% | −26.86% | −25.10% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | 68,300.00 KRW | +1.19% | −17.51% | −14.55% |
| 2HQ0.DE | Tilray Brands, Inc. | 3.94 EUR | +10.21% | −50.43% | −66.96% |
| ANGO | AngioDynamics, Inc. | $15.95 | +16.76% | +25.79% | +64.77% |
| AUTL | Autolus Therapeutics plc | $2.44 | +67.12% | +30.48% | +52.50% |
| 4565.T | Nxera Pharma Co., Ltd. | 1,125.00 JPY | +29.76% | +33.29% | +23.22% |
| VALN | Valneva SE | $6.78 | +36.69% | −24.29% | −28.10% |
| CTNM | Contineum Therapeutics, Inc. | $17.05 | +23.02% | +49.69% | +64.10% |
| VSTM | Verastem, Inc. | $7.08 | +16.45% | −2.07% | −21.16% |
| VLA.PA | Valneva SE | 2.87 EUR | +31.07% | −24.24% | −23.87% |
| KIDS | OrthoPediatrics Corp. | $24.50 | +23.61% | +39.52% | +20.75% |
| SGMT | Sagimet Biosciences Inc. | $10.29 | +38.12% | +71.79% | +45.34% |
| IDX.AX | Integral Diagnostics Limited | 2.40 AUD | +15.38% | −3.07% | −17.78% |
| CTEV | Claritev Corporation | $37.64 | +72.50% | +11.07% | −47.44% |
| 6197.T | Solasto Corporation | 1,118.00 JPY | +0.63% | +30.15% | +135.22% |
| DASA3.SA | Diagnósticos da América S.A. | 2.62 BRL | −8.07% | −41.52% | +111.29% |
| MDXG | MiMedx Group, Inc. | $4.34 | +1.88% | −33.02% | −38.70% |
| CBIO | Crescent Biopharma, Inc. | $17.00 | +0.41% | +53.43% | +15.65% |
| ICLR34.SA | ICON PLC DRN | 41.72 BRL | −2.07% | −17.97% | −14.33% |
| NAN.AX | Nanosonics Limited | 2.94 AUD | −3.61% | −25.00% | −34.23% |
| ARVN | Arvinas, Inc. | $9.60 | +16.79% | −16.30% | +28.34% |
| 3034.T | Qol Holdings Co., Ltd. | 2,589.00 JPY | +21.44% | +26.08% | +25.70% |
| ZURA | Zura Bio Limited | $6.32 | +17.47% | +13.87% | +208.29% |
| ALT | Altimmune, Inc. | $3.20 | +8.11% | −8.83% | −5.60% |
| AQST | Aquestive Therapeutics, Inc. | $5.08 | +36.19% | −21.24% | +31.61% |
| ENTX | Entera Bio Ltd. | $3.47 | −11.48% | +96.05% | +77.95% |
| EQS.PA | Equasens Société anonyme | 34.05 EUR | −0.73% | −24.08% | −26.54% |
| CTKB | Cytek Biosciences, Inc. | $4.58 | +3.85% | −6.91% | +11.44% |
| CRW.L | Craneware plc | 1,296.00 GBP | +6.40% | −32.14% | −40.81% |
| RGNX | REGENXBIO Inc. | $8.91 | −8.24% | −34.34% | −0.67% |
| DCTH | Delcath Systems, Inc. | $16.92 | +41.71% | +70.05% | +55.37% |
| WEAV | Weave Communications, Inc. | $7.29 | +9.62% | +1.67% | −4.33% |
| EOLS | Evolus, Inc. | $8.98 | +45.23% | +33.56% | +20.79% |
| ARTV | Artiva Biotherapeutics, Inc. | $11.77 | +14.05% | +178.25% | +317.38% |
| 4559.T | Zeria Pharmaceutical Co., Ltd. | 2,083.00 JPY | −1.75% | +0.22% | +4.66% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.20 SEK | +3.42% | −15.70% | −30.18% |
| BWAY | BrainsWay Ltd. | $14.43 | −8.44% | +49.61% | +87.89% |
| SPRY | ARS Pharmaceuticals, Inc. | $5.72 | −0.69% | −50.22% | −57.66% |
| OVID | Ovid Therapeutics Inc. | $2.91 | +23.83% | +65.34% | +155.26% |
| 005257.KS | GC Corp. | 16,630.00 KRW | +10.13% | −35.95% | −41.91% |
| EVH | Evolent Health, Inc. | $4.89 | +28.35% | +25.71% | −49.59% |
| FLGT | Fulgent Genetics, Inc. | $19.95 | +1.89% | −22.04% | −7.34% |
| CERS | Cerus Corporation | $2.72 | −11.40% | +38.07% | +112.50% |
| SRTA | Strata Critical Medical, Inc. | $6.19 | +20.43% | +25.56% | +39.10% |
| KYTX | Kyverna Therapeutics, Inc. | $8.84 | +11.62% | +0.80% | +132.02% |
| CABA | Cabaletta Bio, Inc. | $3.22 | +18.38% | +45.70% | +102.52% |
| 003850.KS | Boryung Corporation | 9,100.00 KRW | +14.18% | −2.67% | +10.82% |
| AYA.AX | Artrya Limited | 4.57 AUD | −10.22% | −9.86% | +124.02% |
| 137310.KS | SD Biosensor, Inc. | 6,260.00 KRW | +2.45% | −29.32% | −36.08% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | 13,800.00 KRW | +19.58% | −41.53% | −38.67% |
| 4480.T | Medley, Inc. | 2,797.00 JPY | +40.34% | +19.53% | +8.96% |
| 2664.T | Cawachi Limited | 3,775.00 JPY | +12.52% | +28.94% | +38.71% |
| TCMD | Tactile Systems Technology, Inc. | $23.58 | −15.06% | −13.94% | +81.38% |
| 003090.KS | Daewoong Co., Ltd. | 17,350.00 KRW | +4.33% | −18.93% | −21.68% |
| MPLT | MapLight Therapeutics, Inc. | $12.54 | +26.60% | −25.22% | −31.62% |
| 7979.T | Shofu Inc. | 2,354.00 JPY | +10.83% | +32.29% | +24.45% |
| PRLD | Prelude Therapeutics Incorporated | $6.59 | +69.41% | +141.39% | +418.90% |
| BOI.PA | Boiron SA | 26.00 EUR | −4.76% | −13.62% | +22.93% |
| CVX.PA | CARVOLIX | 6.12 EUR | +10.47% | +235.34% | +235.34% |
| CLPT | ClearPoint Neuro, Inc. | $16.96 | +16.16% | +20.88% | +61.52% |
| CCCC | C4 Therapeutics, Inc. | $4.20 | +16.99% | +117.62% | +66.01% |
| MEDI.OL | Medistim ASA | 256.00 NOK | +13.27% | +1.65% | +1.26% |
| TOI | Starling Oncology Inc | $6.20 | +19.46% | +68.94% | +78.67% |
| CGC | Canopy Growth Corporation | $1.07 | +15.80% | −10.08% | −25.69% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $7.54 | +1.21% | −13.33% | −37.43% |
| WEED.TO | Canopy Growth Corporation | 1.47 CAD | +11.36% | −10.37% | −26.87% |
| EDIT | Editas Medicine, Inc. | $3.28 | +22.39% | +60.00% | +20.59% |
| 3151.T | Vital KSK Holdings, Inc. | 1,677.00 JPY | −0.71% | +21.79% | +41.37% |
| SENS | Senseonics Holdings, Inc. | $9.52 | +90.02% | +61.63% | +4.39% |
| REG1V.HE | Revenio Group Oyj | 14.86 EUR | +19.84% | −32.76% | −38.34% |
| EVMN | Evommune, Inc. | $13.79 | +20.23% | −20.34% | −31.83% |
| KMDA | Kamada Ltd. Ordinary Shares | $8.63 | +23.46% | +26.48% | +26.12% |
| 4592.T | SanBio Company Limited | 1,024.00 JPY | +10.58% | −37.45% | −55.90% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | 1.02 EUR | −0.97% | −91.09% | −91.09% |
| IMR.AX | Imricor Medical Systems, Inc. | 1.93 AUD | −1.28% | +17.74% | +41.54% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $7.42 | +20.26% | −1.98% | +41.87% |
| RLMD | Relmada Therapeutics, Inc. | $4.59 | −11.73% | +5.03% | +635.58% |
| NRC | NRC Health | $22.02 | +3.53% | +23.26% | +48.16% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | 10.20 CAD | +16.70% | −2.49% | +41.67% |
| 4549.T | Eiken Chemical Co., Ltd. | 2,349.00 JPY | −4.59% | −1.31% | −2.85% |
| NPCE | NeuroPace, Inc. | $14.16 | −7.45% | −6.66% | +63.70% |
| QTTB | Q32 Bio Inc. | $16.32 | +7.30% | +374.42% | +728.43% |
| PNV.AX | PolyNovo Limited | 0.98 AUD | +15.29% | −21.60% | −27.14% |
| PRTA | Prothena Corporation plc | $9.42 | +8.28% | +2.39% | +12.41% |
| AGY.L | Allergy Therapeutics plc | 5.60 GBP | +4.09% | −52.94% | −30.00% |
| 317450.KS | MYUNGIN PHARM | 45,750.00 KRW | +12.13% | −25.73% | −55.96% |
| RZLT | Rezolute, Inc. | $5.01 | +1.42% | +131.41% | −28.43% |
| CAPR | Capricor Therapeutics, Inc. | $8.29 | +18.43% | −70.72% | +25.61% |
| OCGN | Ocugen, Inc. | $1.40 | +11.11% | +1.45% | +34.62% |
| PACB | Pacific Biosciences of California, Inc. | $1.52 | +11.76% | −17.39% | +15.15% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | 0.79 EUR | +5.76% | +374.47% | +1150.00% |
| 005690.KS | Pharmicell Co., Ltd. | 10,830.00 KRW | +10.85% | −24.90% | +1.56% |
| PBYI | Puma Biotechnology, Inc. | $9.32 | +16.65% | +61.53% | +86.77% |
| BIOA | BioAge Labs, Inc. | $10.11 | −51.58% | −21.20% | +124.17% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | 3.32 BRL | 0.00% | −46.88% | −5.02% |
| SGHT | Sight Sciences, Inc. | $8.32 | +62.50% | +11.23% | +97.62% |
| HNSA.ST | Hansa Biopharma AB (publ) | 41.84 SEK | +12.90% | +27.95% | +32.57% |
| 001060.KS | JW Pharmaceutical Corporation | 27,200.00 KRW | +17.75% | +7.68% | +28.61% |
| CMPX | Compass Therapeutics, Inc. | $2.53 | +21.63% | −51.06% | −16.23% |
| MASS | 908 Devices Inc. | $11.00 | +54.28% | +116.11% | +75.44% |
| KSI.TO | kneat.com, inc. | 6.50 CAD | +0.31% | +30.52% | +18.83% |
| BNTC | Benitec Biopharma Inc. | $13.02 | +12.44% | +3.46% | −1.44% |
| MCTA | Charming Medical Limited | $29.36 | 0.00% | 0.00% | +319.36% |
| AVCT.L | Avacta Group Plc | 68.80 GBP | +0.44% | +19.65% | +32.31% |
| AVIR | Atea Pharmaceuticals, Inc. | $5.43 | +12.66% | +56.03% | +48.36% |
| 001065.KS | JW Pharmaceutical Corporation | 22,850.00 KRW | +8.81% | −18.02% | −19.15% |
| 000640.KS | Dong-A Socio Holdings Co., Ltd. | 93,100.00 KRW | +6.79% | −10.10% | −12.70% |
| LRMR | Larimar Therapeutics, Inc. | $4.16 | +8.62% | +19.88% | +11.83% |
| CARL | Carlsmed, Inc. | $16.07 | +40.35% | +38.18% | +12.06% |
| CCRN | Cross Country Healthcare Inc | $13.25 | 0.00% | +64.39% | −3.92% |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | 1,188.00 JPY | +0.51% | −21.88% | −19.02% |
| LXEO | Lexeo Therapeutics, Inc. | $5.13 | +14.77% | −46.62% | +10.09% |
| EYPT | EyePoint, Inc. | $5.01 | −59.67% | −71.37% | −56.82% |
| BLAU3.SA | Blau Farmacêutica S.A. | 9.25 BRL | +5.47% | −33.00% | +3.02% |
| RCKT | Rocket Pharmaceuticals, Inc. | $3.78 | +16.31% | +9.25% | +6.78% |
| CEVI.ST | CellaVision AB (publ) | 167.40 SEK | +15.93% | +13.18% | −3.32% |
| XFOR | X4 Pharmaceuticals, Inc. | $4.16 | +5.58% | +6.94% | +4.79% |
| ENTA | Enanta Pharmaceuticals, Inc. | $14.08 | +10.60% | −2.36% | +62.59% |
| FENC | Fennec Pharmaceuticals Inc. | $11.71 | +14.69% | +52.47% | +35.38% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $15.44 | +168.06% | +147.04% | −12.82% |
| LNA.PA | LNA Santé SA | 33.70 EUR | −2.60% | +37.55% | +10.86% |
| FHTX | Foghorn Therapeutics Inc. | $6.85 | +31.73% | +31.98% | +30.48% |
| PRTC.L | PureTech Health plc | 118.80 GBP | +0.51% | −4.65% | −11.34% |
| M12.DE | M1 Kliniken AG | 18.22 EUR | +1.11% | +0.33% | +34.56% |
| GALT | Galectin Therapeutics Inc. | $3.99 | +18.05% | −1.48% | −0.25% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | 545.00 JPY | +5.21% | −19.79% | −7.40% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | 2,621.00 JPY | +6.43% | +30.79% | +28.04% |
| TKNO | Alpha Teknova, Inc. | $7.34 | +51.34% | +88.21% | +63.84% |
| TBRG | TruBridge Inc | $26.24 | 0.00% | +25.55% | +32.06% |
| UPB | Upstream Bio, Inc. | $7.18 | +12.19% | −73.48% | −57.08% |
| IPSC | Century Therapeutics, Inc. | $2.17 | +3.83% | +118.09% | +324.66% |
| OFIX | Orthofix Medical Inc. | $9.64 | −18.99% | −35.04% | −33.52% |
| FRX.TO | Fennec Pharmaceuticals Inc. | 15.49 CAD | +5.73% | +48.80% | +27.38% |
| AUNA | Auna SA | $5.28 | +3.53% | +10.92% | −15.11% |
| E2NO34.SA | Enovis Corporation | 34.59 BRL | +7.86% | +12.74% | −19.24% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.51 SEK | +14.13% | +45.26% | +45.26% |
| ACL.AX | Australian Clinical Labs Limited | 2.89 AUD | +20.42% | +7.73% | +12.06% |
| 4886.T | ASKA Pharmaceutical Holdings Co.,Ltd. | 2,176.00 JPY | −1.67% | +7.18% | −7.07% |
| VOX.WA | Voxel S.A. | 130.40 PLN | +2.68% | +7.24% | −20.15% |
| NIOX.L | NIOX Group Plc | 68.00 GBP | +11.48% | +0.03% | −6.05% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | 1.75 BRL | +186.89% | −35.66% | −41.67% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | 10.54 AUD | +7.44% | −17.07% | −21.84% |
| FYB.DE | Formycon AG | 19.34 EUR | +2.33% | −25.90% | −19.75% |
| LYEL | Lyell Immunopharma, Inc. | $15.49 | +19.52% | −46.55% | +41.20% |
| AGEN | Agenus Inc. | $8.36 | +36.38% | +158.82% | +90.43% |
| CGS.AX | Cogstate Limited | 3.09 AUD | +25.61% | +34.93% | +80.70% |
| CATX | Perspective Therapeutics, Inc. | $3.29 | +16.67% | +17.92% | −4.91% |
| 368A.T | KITAZATO CORPORATION | 1,492.00 JPY | +7.80% | −2.09% | −0.31% |
| SLP | Simulations Plus, Inc. | $18.39 | +0.33% | +1.55% | +31.08% |
| 2395.T | Shin Nippon Biomedical Laboratories, Ltd. | 1,413.00 JPY | +7.37% | −11.06% | −11.06% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $3.88 | −13.97% | +183.21% | +113.19% |
| 019170.KS | Shinpoong Pharmaceutical Co.,Ltd | 9,440.00 KRW | +23.72% | −32.28% | −25.14% |
| VHI.TO | Vitalhub Corp. | 7.96 CAD | +16.20% | −16.56% | −39.14% |
| DMAC | DiaMedica Therapeutics Inc. | $6.74 | 0.00% | −15.01% | +12.33% |
| PALI | Palisade Bio, Inc. | $2.07 | +1.97% | −17.20% | +200.00% |
| HUM.ST | Humana AB (publ) | 70.80 SEK | +13.64% | +44.29% | +73.15% |
| 3733.T | Software Service, Inc. | 12,610.00 JPY | +15.37% | −5.97% | −13.08% |
| 262A.T | INTERMESTIC INC | 1,844.00 JPY | −1.86% | −4.06% | −28.87% |
| OPT.L | Optima Health plc | 238.00 GBP | +3.70% | +19.60% | +8.18% |
| N3B.F | Anbio Biotechnology | 5.50 EUR | −36.78% | −67.46% | −86.59% |
| STRO | Sutro Biopharma, Inc. | $21.44 | −10.70% | +95.62% | +155.24% |
| ABEO | Abeona Therapeutics Inc. | $6.21 | +1.31% | +16.95% | −11.41% |
| MOBI | Mobia Medical, Inc. | $10.63 | −4.49% | −9.53% | −9.53% |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | 12.18 BRL | +4.73% | +2.38% | +23.38% |
| OCA.AX | Oceania Healthcare Limited | 0.68 AUD | +10.66% | −15.62% | +11.57% |
| CRNA.OL | Circio Holding ASA | 10.92 NOK | +21.74% | +795.08% | +1641.63% |
| 377740.KS | BioNote, Inc. | 4,775.00 KRW | +8.40% | −9.74% | −11.35% |
| IKT | Inhibikase Therapeutics, Inc. | $2.50 | +6.38% | +28.21% | +42.05% |
| SABS | SAB Biotherapeutics, Inc. | $3.81 | +10.76% | +1.06% | +72.01% |
| VMD | Viemed Healthcare, Inc. | $9.10 | −24.92% | +26.04% | +28.35% |
| ALCLS.PA | Cellectis S.A. | 2.76 EUR | +9.63% | −34.61% | +19.05% |
| CLLS | Cellectis S.A. | $3.42 | +18.34% | −28.75% | +27.14% |
| NNNN | Anbio Biotechnology | $7.83 | −23.08% | −73.44% | −84.06% |
| 219A.T | HEARTSEED INC | 2,365.00 JPY | +36.94% | +31.02% | −32.33% |
| IMRX | Immuneering Corporation | $5.23 | +19.95% | −21.00% | −12.10% |
| 197A.T | TAUNS LABORATORIES INC. | 503.00 JPY | +6.34% | −0.79% | −11.01% |
| PRQR | ProQR Therapeutics N.V. | $2.38 | +37.57% | +19.60% | +5.78% |
| IRD | Opus Genetics, Inc. | $4.11 | +22.69% | +93.87% | +257.39% |
| 005250.KS | GC Corp. | 10,150.00 KRW | +8.91% | −34.91% | −31.29% |
| P2OD34.SA | Insulet Corporation | 24.68 BRL | −12.58% | −26.20% | −26.20% |
| YDES | YD Bio Ltd | $4.68 | +104.37% | −61.00% | −64.97% |
| AVXL | Anavex Life Sciences Corp. | $3.56 | +42.40% | −3.26% | −62.13% |
| VNDA | Vanda Pharmaceuticals Inc. | $5.44 | +4.21% | −34.06% | +18.00% |
| MATD3.SA | Hospital Mater Dei S.A. | 5.12 BRL | +3.23% | −0.58% | +13.25% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | 13.30 EUR | +2.70% | −49.53% | +40.74% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | 14,400.00 KRW | +9.34% | −62.54% | −39.47% |
| ELMD | Electromed, Inc. | $39.34 | −1.30% | +43.63% | +94.75% |
| ILM1.DE | Medios AG | 10.78 EUR | −11.93% | −26.57% | −27.36% |
| AVH.AX | AVITA Medical, Inc. | 2.92 AUD | +113.14% | +165.45% | +108.57% |
| SBS.DE | Stratec SE | 22.35 EUR | +7.97% | +1.13% | −16.29% |
| OBIO | Orchestra BioMed Holdings, Inc. | $5.36 | +40.31% | +24.36% | +106.15% |
| VICO.ST | Vicore Pharma Holding AB (publ) | 10.60 SEK | −4.33% | −3.46% | −1.85% |
| SMTI | Sanara MedTech Inc. | $34.67 | +34.12% | +50.09% | +5.28% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −0.73% | −21.91% | +20.85% |
| 0120G0.KS | Samyang Biopharm | 58,100.00 KRW | +52.89% | +11.73% | +92.38% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | +0.45% | +40.76% | +28.86% |
| TMCI | Treace Medical Concepts, Inc. | $4.37 | +7.11% | +74.80% | −41.50% |
| TLSI | TriSalus Life Sciences, Inc. | $5.11 | +18.29% | −16.23% | +3.65% |
| 7779.T | CYBERDYNE Inc. | 233.00 JPY | +4.95% | +21.35% | +12.02% |
| RCEL | AVITA Medical, Inc. | $10.50 | +121.05% | +202.59% | +125.81% |
| BCYC | Bicycle Therapeutics plc | $4.39 | +11.14% | −34.28% | −38.34% |
| FATE | Fate Therapeutics, Inc. Common Stock | $2.55 | +4.94% | +157.58% | +133.94% |
| 4554.T | Fuji Pharma Co., Ltd. | 1,869.00 JPY | +0.32% | −1.14% | +31.14% |
| RNAC | Cartesian Therapeutics, Inc. | $10.38 | +33.25% | +53.55% | −7.73% |
| RAC.AX | Racura Oncology Ltd | 2.15 AUD | +5.39% | −25.09% | +72.00% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.50 EUR | +32.85% | +52.78% | +83.33% |
| IFRX | InflaRx N.V. | $2.46 | +44.71% | +125.69% | +167.10% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | 4,155.00 KRW | +7.78% | +8.49% | +28.09% |
| AMRN | Amarin Corporation plc | $14.15 | +2.46% | +3.13% | −8.06% |
| TRDA | Entrada Therapeutics, Inc. | $7.62 | +25.33% | −24.18% | +35.35% |
| BDSX | Biodesix, Inc. | $28.08 | +26.35% | +334.60% | +186.48% |
| TTRX | Turn Therapeutics Inc. | $9.73 | +25.06% | +107.46% | +39.00% |
| FULC | Fulcrum Therapeutics, Inc. | $3.86 | +3.49% | −64.65% | −39.78% |
| CV | CapsoVision, Inc. | $5.85 | −11.50% | −42.87% | +46.62% |
| MYGN | Myriad Genetics, Inc. | $3.19 | −41.47% | −48.05% | −45.84% |
| 4894.T | Cuorips Inc. | 5,670.00 JPY | +37.29% | −8.84% | −19.00% |
| 7777.T | 3-D Matrix, Ltd. | 365.00 JPY | +10.94% | +0.55% | +69.77% |
| EBS | Emergent BioSolutions Inc. | $5.64 | −23.06% | −54.92% | −38.70% |
| PIHLIS.HE | Pihlajalinna Oyj | 10.76 EUR | +3.26% | −22.61% | −30.30% |
| EDT.TO | Spectral Medical Inc. | 1.35 CAD | −2.17% | −2.17% | −3.57% |
| ANIK | Anika Therapeutics, Inc. | $21.40 | +42.48% | +128.88% | +134.39% |
| EMBC | Embecta Corp. | $5.03 | +46.43% | −56.23% | −63.37% |
| SION | Sionna Therapeutics, Inc. | $6.25 | −86.23% | −84.06% | −74.02% |
| ELDN | Eledon Pharmaceuticals, Inc. | $3.47 | −2.80% | +114.20% | +35.02% |
| NMRA | Neumora Therapeutics, Inc. | $1.50 | −9.64% | −9.64% | −7.98% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $4.45 | +30.12% | −25.83% | +185.26% |
| TSTL.L | Tristel plc | 427.50 GBP | +1.79% | −2.27% | +18.80% |
| WHWK | Whitehawk Therapeutics, Inc. | $5.08 | +37.30% | +108.20% | +198.82% |
| AFP.AX | AFT Pharmaceuticals Limited | 3.70 AUD | +2.78% | +23.33% | +54.17% |
| IVVD | Invivyd, Inc. | $0.94 | +53.89% | −62.45% | +67.62% |
| ALXO | ALX Oncology Holdings Inc. | $2.00 | −0.99% | +73.91% | +81.82% |
| LCTX | Lineage Cell Therapeutics, Inc. | $1.13 | +9.71% | −31.10% | −3.42% |
| SRZN | Surrozen, Inc. | $23.36 | +17.92% | +8.40% | +103.13% |
| SUS.ST | Surgical Science Sweden AB (publ) | 49.44 SEK | +47.41% | +59.28% | −50.56% |
| 6078.T | Value HR Co.,Ltd. | 1,625.00 JPY | +5.93% | +6.14% | +5.52% |
| CGEN | Compugen Ltd. | $2.87 | +20.59% | +85.16% | +100.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.